Use of STIMULAN in the treatment of comminuted distal tibial fracture
Courtesy of Prof. James B Richardson
53 year-old male presented with a right ankle fracture.
An Ilizarov external fixator was fitted to the right leg with arthroscopic reconstruction of the right ankle joint. Schanz screws were inserted into the tibia proximally and into the tallus and calcaneus distally all under x-ray control. An articulated ankle and short body fixator was applied and the fracture was distracted.
One month following, decortication of the tibia was performed maintaining external continuity to the periosteum. Proximal extension of the wound was used to reveal the most proximal fracture site. STIMULAN was inserted and a transverse osteotomy was performed 3cm proximal to the ankle joint line (Figure 2). Following the insertion of threaded cancellous bone screws, the open wedge of the osteotomy was also packed with STIMULAN.
The patient stayed on high elevation for a week prior to mobilising again, weight bearing for a short period each day.
At 8 weeks x-ray show advanced absorption of STIMULAN with healing and callus formation evident. (Figure 3).
At 18 months x-ray show total absorption of STIMULAN and healing of the fracture site. (Figure 4).
For indications, contraindications, warnings and precautions see Instructions for Use. The treating physician is responsible for deciding the type and quantity of antibiotic used. Concurrent use of locally administered antibiotics may affect the setting time. The mixing of antibiotics with the STIMULAN Kit / STIMULAN Rapid Cure device has not been assessed by a European medicines Competent Authority and is considered off-label usage of the medicinal product. To do so is at the professional risk of the surgeon / healthcare professional.
This brochure may include the use of STIMULAN or techniques that go beyond the current clearance / approval granted by the relevant regulatory authority. Please contact your local representative for further information.
©2018, Biocomposites, STIMULAN, Bringing Calcium to Life, Power to Transform Outcomes and DRy26 are trademarks/registered trademarks of Biocomposites Ltd. All rights reserved. No unauthorised copying, reproduction, distributing or republication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd.
Patents granted: GB2367552, EP 1204599 B1, US 6780391, EP 2594231 B1, US 8883063, CN ZL201210466117.X, GB2496710, EP 3058899 B1
Patents pending: GB1502655.2, US 15/040075, CN 201610089710.5, US 15/288328, GB1704688.9, EP 18275044.8, US 15/933936